Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G238 (Eberconazole) vs Clotrimazole in Otomycosis
NCT01993823Phase 3Completed
- Sponsor
- Laboratorios Salvat
- Start
- May 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eberconazole in otomycosis, sponsored by Laboratorios Salvat. Started May 2013; status: completed.
02
Drugs
eberconazole
03
Conditions
otomycosis
Beyond the preview
Go deeper on NCT01993823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993823.